Search results
David S. Eisenberg (born 15 March 1939 [citation needed]) is an American biochemist and biophysicist best known for his contributions to structural biology and computational molecular biology.
David Eisenberg is currently Professor of Chemistry and Biochemistry and Biological Chemistry, as well as HHMI Investigator and Director of the UCLA-DOE Institute for Genomics and Proteomics.
Research Overview. David Eisenberg and his research group focus on protein interactions. In their experiments they study the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state.
Articles 1–20. Paul Boyer Professor, HHMI-UCLA - Cited by 122,192 - Proteins - amyloid - structural biology.
Structure-based discovery of small molecules that disaggregate Alzheimer's disease tissue derived tau fibrils in vitro Nat Commun. 2022 Sep 16;13 (1):5451. 2022 PMID: 36114178.
Research Activities and Funding. Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias. NIH U24AG072458 Jul 1, 2021 - Jun 30, 2026. Role: Co-Principal Investigator.
David Eisenberg is a Professor of Chemistry and Biochemistry and of Biological Chemistry at the University of California, Los Angeles, and Director of the UCLA-DOE Institute for Genomics and Proteomics.
Oct 26, 1995 · Eisenberg Research Group Key words: Molecular Biology and Physical Chemistry: protein structure; protein folding and design profiles; protein stability and biological recognition.
David Eisenberg is currently Professor of Chemistry and Biochemistry and Biological Chemistry, as well as HHMI Investigator and Director of the UCLA-DOE Institute for Genomics and Proteomics.
David S. Eisenberg is an American biochemist and biophysicist best known for his contributions to structural biology and computational molecular biology.
